loceryl has been researched along with Candidiasis, Vulvovaginal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryson, HM; Haria, M | 1 |
| Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
| Polak, A | 1 |
2 review(s) available for loceryl and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Dermatomycoses; Female; Humans; Microbial Sensitivity Tests; Morpholines; Onychomycosis | 1995 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
1 other study(ies) available for loceryl and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Preclinical data and mode of action of amorolfine.
Topics: Animals; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Dermatomycoses; Disease Models, Animal; Female; Guinea Pigs; Humans; Mice; Morpholines; Sterols; Tinea | 1992 |